New Bacterial VaccinesRonald W. Ellis, Bernard R. Brodeur Springer Science & Business Media, 2003. nov. 30. - 359 oldal New Bacterial Vaccines focuses upon unfulfilled needs for bacterial vaccines. The increase in drug resistance among many bacterial species has increased the need for new bacterial vaccines. This book serves as a comprehensive reference on the major aspects of developing new bacterial vaccines. The distinctive feature of this book is that it focuses upon new vaccines now under development by reviewing key issues for each vaccine target and new technologies being applied to developing new vaccines. This book should prove useful for students in the life sciences, scientists, developers of vaccines and biotechnology products, clinicians, regulators, and health-care practitioners. |
Tartalomjegyzék
II | 1 |
III | 2 |
IV | 4 |
V | 7 |
VI | 8 |
VII | 9 |
VIII | 12 |
IX | 15 |
LXXXVI | 195 |
LXXXVII | 196 |
LXXXVIII | 197 |
LXXXIX | 202 |
XC | 203 |
XCI | 205 |
XCIII | 206 |
XCIV | 207 |
X | 19 |
XI | 26 |
XII | 28 |
XIII | 30 |
XV | 31 |
XVI | 33 |
XVII | 34 |
XVIII | 37 |
XIX | 45 |
XX | 46 |
XXI | 57 |
XXII | 63 |
XXIII | 65 |
XXIV | 68 |
XXV | 69 |
XXVI | 73 |
XXVII | 74 |
XXVIII | 80 |
XXIX | 83 |
XXX | 84 |
XXXI | 88 |
XXXIII | 90 |
XXXIV | 93 |
XXXVII | 94 |
XXXVIII | 96 |
XXXIX | 98 |
XL | 99 |
XLII | 103 |
XLV | 104 |
XLVII | 105 |
XLVIII | 110 |
XLIX | 111 |
L | 115 |
LI | 128 |
LII | 129 |
LV | 136 |
LVI | 137 |
LVII | 139 |
LVIII | 140 |
LIX | 142 |
LXI | 143 |
LXII | 145 |
LXIII | 155 |
LXVI | 156 |
LXVII | 157 |
LXIX | 158 |
LXXI | 159 |
LXXII | 160 |
LXXIII | 163 |
LXXV | 165 |
LXXVI | 167 |
LXXVII | 174 |
LXXVIII | 176 |
LXXIX | 178 |
LXXX | 184 |
LXXXI | 185 |
LXXXII | 186 |
LXXXIII | 192 |
LXXXIV | 193 |
XCV | 208 |
XCVII | 210 |
XCVIII | 211 |
XCIX | 212 |
C | 217 |
CI | 219 |
CIII | 220 |
CIV | 221 |
CV | 224 |
CVI | 229 |
CVII | 230 |
CVIII | 232 |
CX | 236 |
CXI | 238 |
CXII | 239 |
CXIII | 244 |
CXIV | 248 |
CXV | 249 |
CXVI | 252 |
CXVII | 260 |
CXVIII | 262 |
CXIX | 265 |
CXX | 266 |
CXXI | 267 |
CXXII | 268 |
CXXIV | 269 |
CXXV | 272 |
CXXVI | 273 |
CXXVII | 283 |
CXXVIII | 284 |
CXXIX | 288 |
CXXXI | 290 |
CXXXII | 291 |
CXXXIII | 294 |
CXXXIV | 295 |
CXXXV | 297 |
CXXXVI | 300 |
CXXXVII | 303 |
CXXXVIII | 304 |
CXXXIX | 305 |
CXLI | 311 |
CXLII | 313 |
CXLIII | 314 |
CXLIV | 315 |
CXLV | 316 |
CXLVI | 319 |
CXLVII | 320 |
CXLIX | 321 |
CL | 326 |
CLI | 327 |
CLII | 331 |
CLIII | 333 |
CLIV | 339 |
CLV | 340 |
CLVI | 341 |
CLVII | 342 |
CLVIII | 345 |
351 | |
Más kiadások - Összes megtekintése
Gyakori szavak és kifejezések
acid activity adhesin adjuvant adults animal models antibody responses antigens aureus Bacterial Vaccines bactericidal binding Borrelia burgdorferi challenge Chlamydia cholera Clin clinical trials colonization conjugate vaccines DNA vaccines dose effective efficacy elicit encoding epithelial cells epitopes Escherichia coli ETEC evaluated expression gene genetic genome gonococcal Haemophilus influenzae Helicobacter pylori host human immune response immunogenicity Immunol immunological induce Infect Immun 1999 Infect Immun 2001 intranasal invasive isolates Lyme disease meningococcal mice Mol Microbiol molecular MOMP mouse mucosal immune mutant Natl Acad Sci Neisseria gonorrhoeae Neisseria meningitidis nontypeable Haemophilus influenzae NTHI oral OspA otitis media outer membrane protein pathogenesis pathogens patients peptides plasmid pneumococcal polysaccharide potential Proc Natl Acad protective immunity Pseudomonas aeruginosa PspA purified receptor recombinant sequence serogroup serotypes serum strains Streptococcus pneumoniae studies subunit surface protein toxin toxoid trachomatis tuberculosis typhi typhimurium vaccine antigens vaccine candidates vaccine development vectors virulence vitro vivo volunteers